Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
المؤلفون الرئيسيون: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
PeerJ Inc.
2021-04-01
|
سلاسل: | PeerJ |
الموضوعات: | |
الوصول للمادة أونلاين: | https://peerj.com/articles/11175.pdf |
مواد مشابهة
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
حسب: Emily J.R. Carter, وآخرون
منشور في: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
حسب: Qin Xiang Ng, وآخرون
منشور في: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
حسب: Telmo Martínez, وآخرون
منشور في: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
حسب: Payal H. Desai, PharmD, BCCCP, وآخرون
منشور في: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
حسب: Paolo Marchettini, وآخرون
منشور في: (2005-05-01)